Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPIL
1801
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $1.8M | ﹤0.01% |
300,700
-125,800
| -29% | -$740K |
|
|
ESGR
1802
DELISTED
Enstar Group
ESGR
| $1.79M | ﹤0.01% |
12,900
+4,000
| +45% | +$548K |
|
1803
Scully Royalty
SRL
$76.9M
| $1.79M | ﹤0.01% |
44,858
+29,635
| +195% | +$1.18M |
|
|
ZIXI
1804
DELISTED
Zix Corporation
ZIXI
| $1.79M | ﹤0.01% |
393,000
+176,100
| +81% | +$793K |
|
|
CAVM
1805
DELISTED
Cavium, Inc.
CAVM
| $1.79M | ﹤0.01% |
+51,900
| New | +$1.94M |
|
1806
Crawford & Co Class B
CRD.B
$489M
| $1.79M | ﹤0.01% |
193,700
-11,500
| -6% | -$112K |
|
|
MSB
1807
Mesabi Trust
MSB
$301M
| $1.79M | ﹤0.01% |
80,400
+23,300
| +41% | +$517K |
|
|
DZSI
1808
DELISTED
DZS Inc. Common Stock
DZSI
| $1.79M | ﹤0.01% |
66,928
-37,940
| -36% | -$812K |
|
1809
Fabrinet
FN
$15.7B
| $1.78M | ﹤0.01% |
86,600
-104,500
| -55% | -$1.93M |
|
|
ANAC
1810
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.77M | ﹤0.01% |
+105,800
| New | +$1.46M |
|
|
PHLT
1811
DELISTED
Performant Healthcare Inc
PHLT
| $1.77M | ﹤0.01% |
+172,200
| New | +$1.74M |
|
|
PTVCB
1812
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $1.77M | ﹤0.01% |
64,900
-9,100
| -12% | -$241K |
|
|
FORTY
1813
Formula Systems
FORTY
$1.63B
| $1.77M | ﹤0.01% |
70,600
+1,800
| +3% | +$45.3K |
|
1814
RCI Hospitality Holdings
RICK
$197M
| $1.77M | ﹤0.01% |
152,700
+10,200
| +7% | +$114K |
|
1815
Rogers Corp
ROG
$2.18B
| $1.76M | ﹤0.01% |
28,700
+23,800
| +486% | +$1.43M |
|
|
DYN
1816
DELISTED
Dynegy, Inc.
DYN
| $1.76M | ﹤0.01% |
81,900
-50,500
| -38% | -$1.03M |
|
1817
KT
KT
$8.8B
| $1.76M | ﹤0.01% |
118,068
-102,732
| -47% | -$1.61M |
|
|
SPNC
1818
DELISTED
Spectranetics Corp
SPNC
| $1.76M | ﹤0.01% |
70,222
+6,222
| +10% | +$133K |
|
1819
Enanta Pharmaceuticals
ENTA
$378M
| $1.75M | ﹤0.01% |
+64,300
| New | +$1.56M |
|
|
UCTT
1820
Ultra Clean Holdings
UCTT
$3.73B
| $1.75M | ﹤0.01% |
174,200
+83,790
| +93% | +$754K |
|
|
JRJC
1821
DELISTED
China Finance Online Co., Ltd.
JRJC
| $1.75M | ﹤0.01% |
27,750
+1,070
| +4% | +$35.9K |
|
|
RTI
1822
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $1.74M | ﹤0.01% |
+50,900
| New | +$1.73M |
|
1823
Dine Brands
DIN
$457M
| $1.74M | ﹤0.01% |
20,800
+600
| +3% | +$47.3K |
|
1824
Myers Industries
MYE
$1.24B
| $1.73M | ﹤0.01% |
82,100
-156,200
| -66% | -$3.04M |
|
|
IGLD
1825
DELISTED
Internet Gold-Golden Lines Ltd
IGLD
| $1.72M | ﹤0.01% |
2,013
+311
| +18% | +$347K |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.